KIDS at a glance
ORTHOPEDIATRICS CORP (KIDS, SEC CIK 1425450) filed its latest 10-K annual report on March 4, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on August 4, 2026 and Form 4 insider filings as recently as September 11, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended December 31, 2025 (FY2025), ORTHOPEDIATRICS CORP (KIDS) reported revenue of $236.3 million (up 15.4% from FY2024) and a net loss of $39.6 million. Diluted EPS was -$1.69.
- As of June 30, 2026, 25 institutional investment managers tracked by SignalX reported holding ORTHOPEDIATRICS CORP (KIDS) shares worth $109.5 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by Pelizzon David R on September 10, 2026 of 302,369 shares at $21.01 per share.
- In the last 90 days, KIDS insiders reported 0 open-market purchases ($0) and 21 open-market sales ($46.7M) on Form 4, a net sale of $46.7M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $236.3M
- +15.4% vs prior year
- Insiders · 90 days
- 0 buys · 21 sells
- Net −$46.7M
- 13F holders
- 25 funds
- $109.5M · +3 vs prior quarter
- Latest 8-K
- Aug 4, 2026
- Item 2.02
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jun 30, 2026
Risk Factors
- No material changes to risk factors since March 4, 2026 Form 10-K
- Regulatory risk: UK distributor acquisition involved 80,873 unregistered shares issued under Section 4(a)(2)
- Acquisition integration risk: UK medical-device distributor purchased for $1,398,666 in stock
AI summary of the KIDS 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 2.02: Results of Operations and Financial Condition
- Q2 2026 earnings release for quarter ended June 30, 2026
- Unaudited condensed consolidated financial statements furnished as Exhibit 99.1
Item 7.01: Regulation FD Disclosure
- Upcoming investor and analyst presentations by OrthoPediatrics executives
- Exhibit 99.1 contains the presentation materials intended for market disclosure
Item 5.07: Submission of Matters to a Vote of Security Holders
- All four director nominees elected through 2029, including George Dyer with 10,843,747 votes for and 8,009,267 withheld
- Executive compensation advisory vote approved, with 15,953,457 votes for and 2,859,793 against
AI summaries of KIDS 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for KIDS
Don't miss the next KIDS filing
- Alerts as it files. A push when KIDS files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut KIDS, by share count.
- Ask anything. An AI agent that reads every KIDS filing and answers with sources.
KIDS alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Pelizzon David R | Sell | Sep 10, 2026 | 302,369 | $21.01 |
| Squadron Capital LLC | Sell | Sep 10, 2026 | 302,369 | $21.01 |
| Pritzker Jennifer N. | Sell | Sep 10, 2026 | 302,369 | $21.01 |
| Pritzker Jennifer N. | Sell | Sep 2, 2026 | 22,500 | $23.35 |
| Pelizzon David R | Sell | Sep 2, 2026 | 22,500 | $23.35 |
| Squadron Capital LLC | Sell | Sep 2, 2026 | 22,500 | $23.35 |
| Pritzker Jennifer N. | Sell | Sep 1, 2026 | 10,131 | $23.10 |
| Pelizzon David R | Sell | Sep 1, 2026 | 10,131 | $23.10 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $204.7M | $236.3M |
| Gross Profit | - | $148.6M | $172.7M |
| Operating Income | - | -$35.0M | -$39.2M |
| Net Income | - | -$37.8M | -$39.6M |
| Gross Margin | - | 72.6% | 73.1% |
| Op. Margin | - | -17.1% | -16.6% |
| Net Margin | - | -18.5% | -16.8% |
| Balance Sheet | |||
| Total Assets | $438.7M | $473.2M | $508.6M |
| Equity | $377.0M | $354.6M | $346.6M |
| ROE | - | -10.7% | -11.4% |
| Per Share | |||
| EPS | - | $-1.64 | $-1.69 |
| Cash Flow | |||
| Operating CF | - | -$27.0M | -$4.9M |
| CapEx | - | $14.3M | $11.1M |
Source: XBRL data in ORTHOPEDIATRICS CORP (KIDS)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate KIDS share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 25 | $109.5M |
| Q1 2026 | 22 | $99.6M |
| Q4 2025 | 21 | $114.5M |
| Q3 2025 | 20 | $108.6M |
| Q2 2025 | 20 | $125.1M |
| Q1 2025 | 17 | $108.9M |
| Q4 2024 | 14 | $65.2M |
| Q3 2024 | 13 | $35.3M |
- Citadel Advisors LLC+149.3K (+81%)
- BlackRock+98.7K (+8%)
- Vanguard Capital Management LLC+37.4K (+5%)
- Vanguard Portfolio Management LLC+21.0K (+14%)
- D.E. Shaw & Co+18.3K (+25%)
- Morgan Stanley−447.7K (-39%)
- Millennium Management−420.1K (-34%)
- Dimensional Fund Advisors−65.8K (-12%)
- Goldman Sachs Group−37.7K (-11%)
- State Street Corp−22.4K (-5%)
- AQR Capital Management+78.3K
- Principal Financial Group+14.6K
- Two Sigma Investments+10.6K
Source: 13F-HR filings on SEC EDGAR (aggregated from 152 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
KIDS filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
10-Q quarterly reports
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Sep 11, 2026 | - | - | - |
| 4 | Sep 11, 2026 | - | - | - |
| 4 | Sep 10, 2026 | - | - | - |
| 4 | Sep 4, 2026 | - | - | - |
| 4 | Sep 4, 2026 | - | - | - |
| 4 | Sep 4, 2026 | - | - | - |
| 4 | Sep 1, 2026 | - | - | - |
| 4 | Sep 1, 2026 | - | - | - |
| 4 | Sep 1, 2026 | - | - | - |
| 4 | Aug 26, 2026 | - | - | - |
| 4 | Aug 26, 2026 | - | - | - |
| 4 | Aug 26, 2026 | - | - | - |
| 10-Q | Aug 5, 2026 | Jun 30, 2026 | Analysis | |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 8-K | Aug 4, 2026 | - | Analysis | - |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - | |
| 4 | Jun 10, 2026 | - | - |
Related Health Care companies
- ARAY · ACCURAY INCSurgical & Medical Instruments & Apparatus
- ATEC · Alphatec Holdings, Inc.Surgical & Medical Instruments & Apparatus
- ANGO · ANGIODYNAMICS INCSurgical & Medical Instruments & Apparatus
- ANIK · Anika Therapeutics, Inc.Surgical & Medical Instruments & Apparatus
- AORT · ARTIVION, INC.Surgical & Medical Instruments & Apparatus
- ATRC · AtriCure, Inc.Surgical & Medical Instruments & Apparatus
- RCEL · AVITA Medical, Inc.Surgical & Medical Instruments & Apparatus
- BAX · Baxter InternationalSurgical & Medical Instruments & Apparatus
KIDS SEC filings: frequently asked questions
Are KIDS insiders buying or selling?
In the last 90 days, ORTHOPEDIATRICS CORP (KIDS) officers, directors and 10% owners reported no open-market purchases and 21 open-market sales worth $46.7 million by 3 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold KIDS stock?
As of June 30, 2026, the largest ORTHOPEDIATRICS CORP (KIDS) holders among the 13F filers tracked by SignalX were BlackRock ($24.3 million), Millennium Management ($15.6 million), Vanguard Capital Management LLC ($14.5 million), Morgan Stanley ($13.3 million), Dimensional Fund Advisors ($9.2 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was KIDS's revenue in fiscal year 2025?
For the fiscal year ended December 31, 2025 (FY2025), ORTHOPEDIATRICS CORP (KIDS) reported revenue of $236.3 million (up 15.4% from FY2024) and a net loss of $39.6 million. Diluted EPS was -$1.69. The figures come from the XBRL data in the 10-K.
What did KIDS report in its latest 8-K?
ORTHOPEDIATRICS CORP (KIDS) filed an 8-K on August 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 2026 earnings release for quarter ended June 30, 2026.
What are the latest KIDS SEC filings?
ORTHOPEDIATRICS CORP (KIDS) filed its latest 10-K annual report on March 4, 2026, a 10-Q quarterly report on August 5, 2026, an 8-K current report on August 4, 2026 and a Form 4 insider filing on September 11, 2026.
What is KIDS's SEC CIK number?
ORTHOPEDIATRICS CORP (KIDS)'s SEC Central Index Key (CIK) is 1425450. EDGAR lists every KIDS filing under that number.
Ask anything about KIDS
The research agent reads KIDS's filings, financials, insider trades and 13F holders, then answers with sources.